Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
GLP-1 receptor agonists, or glucagon-like peptide-1 receptor agonists, were first developed to help people with type 2 diabetes manage their blood sugar levels
Not only is there a rapid weight gain for most patients, but there is documented re-worsening of comorbidities such as cardiovascular risk factors. The new insurance restrictions have fueled the use of direct-to-consumer programs such as NovoCare and LillyDirect, where prices range from $149 to $449 a month, depending on the drug and dosage
for 1 year
Clinical studies suggest both medications can produce substantial body weight reductions, but Tirzepatide generally demonstrates greater average outcomes
US$ 25.81
US$ 26.17
US$ 21.16
US$ 23.76
US$ 22.58
US$ 27.33
US$ 22.07
US$ 27.22
US$ 26.76
